Quanterix Corporation, a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced that it will be presenting at the 21st Annual Needham Growth Conference, on Jan. 16, at 4:10 p.m., EST, at the Lotte New York Palace Hotel, New York City.
To access the live webcast of Quanterix’ presentations, please visit the News & Events page within the Investors section of the Quanterix website at www.quanterix.com. Replays of the webcast will be available on the Quanterix website for 90 days following the conference.
Quanterix’s Simoa® technology drives advances in Alzheimer’s disease research presented at 2022 Clinical Trials On Alzheimer’s Disease (CTAD) conference